iBio, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
iBio, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2011 to Q3 2024.
  • iBio, Inc. Entity Common Stock, Shares Outstanding for the quarter ending September 19, 2024 was 8.64M shares, a 68.7% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 8.64M -18.9M -68.7% Sep 19, 2024 10-K/A 2024-09-24
Q1 2024 8.62M -8.17M -48.7% May 9, 2024 10-Q 2024-05-13
Q4 2023 3.48M -8.88M -71.8% Feb 8, 2024 10-Q 2024-02-09
Q3 2023 27.6M +18.6M +206% Sep 26, 2023 10-K 2023-09-27
Q1 2023 16.8M -201M -92.3% May 10, 2023 10-Q 2023-05-15
Q4 2022 12.4M -206M -94.3% Feb 7, 2023 10-Q/A 2023-05-19
Q3 2022 9.01M -209M -95.9% Oct 10, 2022 10-K 2022-10-11
Q1 2022 218M +2.16M +1% May 9, 2022 10-Q 2022-05-12
Q4 2021 218M +36M +19.8% Jan 26, 2022 10-Q 2022-02-14
Q3 2021 218M +37.6M +20.8% Sep 22, 2021 10-K 2021-09-28
Q2 2021 218M May 17, 2021 10-Q 2021-05-17
Q1 2021 216M +97.6M +82.5% Feb 16, 2021 10-Q 2021-02-16
Q4 2020 182M +106M +139% Nov 16, 2020 10-Q 2020-11-16
Q3 2020 180M +156M +646% Oct 8, 2020 10-K 2020-10-13
Q1 2020 118M +98.7M +501% May 15, 2020 10-Q 2020-05-15
Q4 2019 76.2M +57.2M +300% Feb 12, 2020 10-Q 2020-02-14
Q3 2019 24.2M +5.82M +31.7% Aug 26, 2019 10-K 2019-08-26
Q1 2019 19.7M -96.2M -83% May 9, 2019 10-Q 2019-05-10
Q4 2018 19M -96.3M -83.5% Feb 4, 2019 10-Q 2019-02-13
Q3 2018 18.3M -74.5M -80.2% Sep 14, 2018 10-K 2018-09-18
Q1 2018 116M +26.8M +30.1% May 11, 2018 10-Q 2018-05-11
Q4 2017 115M +26.2M +29.4% Feb 14, 2018 10-Q 2018-02-14
Q3 2017 92.8M +3.71M +4.16% Sep 15, 2017 10-K 2017-09-15
Q1 2017 89.1M +6.5M +7.87% Feb 21, 2017 10-Q 2017-02-21
Q4 2016 89.1M Nov 18, 2016 10-Q 2016-11-18
Q3 2016 89.1M +11.8M +15.2% Oct 12, 2016 10-K 2016-10-13
Q2 2016 89.1M May 23, 2016 10-Q 2016-05-23
Q1 2016 82.6M +8.63M +11.7% Feb 19, 2016 10-Q 2016-02-22
Q3 2015 77.3M +9.87M +14.6% Oct 5, 2015 10-K 2015-10-13
Q1 2015 74M +8.34M +12.7% Feb 23, 2015 10-Q/A 2015-02-24
Q3 2014 67.5M +10.8M +19% Sep 26, 2014 10-K 2014-09-29
Q1 2014 65.6M +17.9M +37.4% May 15, 2014 10-Q 2014-05-15
Q4 2013 65.6M Feb 13, 2014 10-Q 2014-02-14
Q3 2013 56.7M +8.93M +18.7% Sep 10, 2013 10-K/A 2013-10-04
Q1 2013 47.8M 0 0% Feb 19, 2013 10-Q 2013-02-19
Q3 2012 47.8M +15.4M +47.5% Sep 14, 2012 10-K/A 2012-10-15
Q1 2012 47.8M May 15, 2012 10-Q 2012-05-15
Q4 2011 47.8M Feb 14, 2012 10-Q 2012-02-14
Q3 2011 32.4M Nov 14, 2011 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.